Gut Microbiota and Stool Frequency
NCT03153059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2017-12-04
Summary
We hypothesized that some difference in the composition and distribution of gut microbiota in people with a large number of defecation (two or three times a day or more), people with normal defecation (one time a day or two days), and people with a small number of defecation (two times a week or less).
And we investigate the association between gut microbiota and stool frequency.
Conditions
- Gut Microbiota
Interventions
- OTHER
-
Stool frequency
This study is just observational study.
Sponsors & Collaborators
-
Kosin University Gospel Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-05-11
- Primary Completion
- 2017-09-30
- Completion
- 2017-10-30
Countries
- South Korea
Study Locations
More Related Trials
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Fecal Microbiota Transplantation
NCT04706611 ·Status: RECRUITING ·Phase: NA
-
Microbiome of the Ageing Gut and Its Effect on Human Gut Health and Cognition.
NCT04199195 ·Status: ACTIVE_NOT_RECRUITING
-
Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
NCT02566629 ·Status: UNKNOWN
-
Multi-omics Dissection of Gut Microbiome Engraftment During FMT
NCT06992453 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effectiveness of Temple Stay in Irritable Bowel Syndrome
NCT05999500 ·Status: RECRUITING
-
Metagenome Analysis of Gut Microbiota in CC Patients
NCT02395484 ·Status: UNKNOWN
-
The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.
NCT06208930 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults
NCT06297421 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
NCT02651740 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT03613545 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
Dynamic Changes of Gut Microbiota in UC After FMT
NCT03949257 ·Status: UNKNOWN ·Phase: NA
-
Probiotics and Gut Health
NCT01874301 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation
NCT05803993 ·Status: RECRUITING ·Phase: NA
-
Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders
NCT05753774 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT06960369 ·Status: RECRUITING ·Phase: PHASE1
-
Effect of Intensive FMT on Primary Hypertension
NCT05608447 ·Status: UNKNOWN ·Phase: PHASE1
-
The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study
NCT02516683 ·Status: COMPLETED
-
Elemental Diet and Gut Microbiome
NCT05978973 ·Status: COMPLETED ·Phase: NA
-
Effects of Faecal Microbiota Transplantation in Patients With IBS
NCT03822299 ·Status: COMPLETED ·Phase: NA
-
Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
NCT03557788 ·Status: COMPLETED ·Phase: PHASE4